City of Hope

The year 2025 is set top be a pivotal one for the biopharma industry, marked by significant political changes in the US and beyond. Around half the world’s population live in countries that held natio

Presentations from 12 big pharma companies at a pre-AACR event highlighted common interests in therapeutic modalities that have driven recent dealmaking in the industry – antibody-drug conjugates (ADC

Figuring out how to get a foot in the door with potential big pharma partners is a daunting task for academic researchers and small biotechnology companies. The organizers of the inaugural American As

The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o